Skip to main content
Caplight Logo









MPC Therapeutics AG

MPC Therapeutics AG

Private
SchlierenHealthcare & Life Scienceshttps://www.mpc-therapeutics.com/

Last Round

Seed

Nov 16, 2023

Total Funding Raised

$1.74M

Company Overview

MPC Therapeutics AG is a biotechnology research company that develops a new generation of cancer therapies that modulate transcription.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

MPC inhibitorcell therapy enhancementsmall molecule therapeuticsCAR-T enhancementcell metabolism reprogrammingmitochondrial modulatorsex-vivo manufacturingT-cell quality enhancerstem cell memory T cellsTscmbiomanufacturingcell therapy reagentdrug discoveryneurodegenerative diseasekidney disease

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MPC Therapeutics AG Comparables

Compare MPC Therapeutics AG with similar companies based on industry and business-model similarity.

MPC Therapeutics AG comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Miltenyi Biotec
63%
Lmito Therapeutics
63%
Thermo Fisher Scientific Inc.
60%

MPC Therapeutics AG Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 16, 2023
SeedJan 10, 2023

Key People

Founding team and executive leadership

Raphaël Martinou

Co-founder & CEO

Founding Team

MPC Therapeutics AG Investors

Notable investors and investment history

MPC Therapeutics AG investors
InvestorRounds
Plutus Investment GroupSeed
FongitSeed
Venture KickAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 2, 2025

    Monthly visitors grew 146% MoM, reaching 5.9K.

  • Dec 16, 2024

    Monthly visitors grew 213% MoM, reaching 4.7K.

MPC Therapeutics AG Filings

Explore SEC and related filing metadata, where available.

MPC Therapeutics AG filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about MPC Therapeutics AG's valuation, stock price, and market status.

Is MPC Therapeutics AG a public or private company?

MPC Therapeutics AG is a private company.

What is the current stock price of MPC Therapeutics AG?

MPC Therapeutics AG is a private company with no public stock price. No recent secondary market data is available.

How much is MPC Therapeutics AG worth (valuation)?

Valuation information for MPC Therapeutics AG is not publicly available.

Can I buy MPC Therapeutics AG stock?

MPC Therapeutics AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was MPC Therapeutics AG's last funding round?

MPC Therapeutics AG's most recent funding round was Seed on November 16, 2023.

Who are the main investors in MPC Therapeutics AG?

Key investors in MPC Therapeutics AG include Plutus Investment Group.

Will MPC Therapeutics AG IPO soon?

No public IPO plans have been announced for MPC Therapeutics AG.

How can I track MPC Therapeutics AG secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor MPC Therapeutics AG's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSchlieren
Employee Range6
Year Founded2019
Last FundingNov 16, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?